To study whether the levels of NEK2 in ccRCC patients were consistent with the results of bioinformatics analysis, we collected 30 pairs of ccRCC tissues and adjacent noncancerous tissues to estimate NEK2 expression by Western blotting. The gene discussed is NEK2; the disease is nonpapillary renal cell carcinoma.